Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Medical use of cannabis products : Lessons to be learned from Israel and Canada.
Subgroup analysis in MS trials.
Behavioral measurement of laser flashblindness in rhesus monkeys.
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
A study on the direct and indirect costs of multiple sclerosis based on expanded disability status scale score in khuzestan, iran.
Assessment of Dysmyelination with RAFFn MRI: Application to Murine MPS I.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Modeling cognition and disease using human glial chimeric mice.
Vestibular and ocular motor function prior to and after therapeutic apheresis with small plasmafilter in multiple sclerosis.
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Coping and its importance for quality of life in patients with multiple sclerosis.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.
Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.
Pages
« first
‹ previous
…
680
681
682
683
684
685
686
687
688
…
next ›
last »